StockComparison Logo
vs

CANC vs FAAR

Comparison between Tema Oncology ETF (CANC, ETF) and FIRST TRUST ALTERNATIVE ABSOLUTE RETURN STRATEGY ETF (FAAR, ETF).

5-Year PerformanceFAAR has outperformed CANC, delivering a return of +7.5% compared to -9.4%

CANC vs FAAR - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Net Assets
Winner
CANC
$176M
FAAR
$176M
Expense Ratio
Winner
CANC
0.75%
FAAR
0.98%
Max Drawdown
CANC
97.53%
Winner
FAAR
27.93%
Sharpe Ratio
CANC
1.58
Winner
FAAR
1.93
5Y Beta
CANC
0.76
Winner
FAAR
0.15
P/E Ratio
CANC
-24.37
FAAR
N/A
5Y Dividends CAGR
CANC
N/A
FAAR
31.47%
5Y EPS CAGR
CANC
11.01%
FAAR
N/A
Debt to Equity
CANC
58.15%
FAAR
N/A
P/S Ratio
CANC
8.49
FAAR
N/A
P/B Ratio
CANC
5.96
FAAR
N/A

CANC vs FAAR - Holdings Comparison

CANC and FAAR have 0 common holdings. Overlap is 0.00%

CANC's top 25 holdings weight is 76.89%. FAAR's top 25 holdings weight is 16.37%.

RankCANCFAAR
#1
REVOLUTION MEDICINES INC ORDINARY SHARES (RVMD) - 7.31%
MORGAN STANLEY INSTL LQUDTY TRS INSTL (MISXX) - 16.37%
#2
ELI LILLY AND CO (LLY) - 4.25%
N/A
#3
IMMUNOME INC ORDINARY SHARES (IMNM) - 4.21%
N/A
#4
COGENT BIOSCIENCES INC (COGT) - 4.08%
N/A
#5
ROCHE HOLDING AG ADR (RHHBY) - 4.07%
N/A
#6
NOVARTIS AG REGISTERED SHARES (n/a) - 4.00%
N/A
#7
CELCUITY INC (CELC) - 3.93%
N/A
#8
ASTRAZENECA PLC (AZN:XLON) - 3.50%
N/A
#9
MERCK & CO INC (MRK) - 3.43%
N/A
#10
BRISTOL-MYERS SQUIBB CO (BMY) - 3.34%
N/A
#11
NUVALENT INC CLASS A (NUVL) - 3.15%
N/A
#12
LEGEND BIOTECH CORP ADR (LEGN) - 2.94%
N/A
#13
GENMAB AS ADR (GMAB) - 2.87%
N/A
#14
ABBVIE INC (ABBV) - 2.70%
N/A
#15
BRIDGEBIO PHARMA INC (BBIO) - 2.63%
N/A
#16
CG ONCOLOGY INC (CGON) - 2.56%
N/A
#17
JOHNSON & JOHNSON (JNJ) - 2.55%
N/A
#18
ZAI LAB LTD ADR REPR 1 SHS (ZLAB) - 2.49%
N/A
#19
EXELIXIS INC (EXEL) - 2.45%
N/A
#20
IDEAYA BIOSCIENCES INC (IDYA) - 2.10%
N/A
#21
AMGEN INC (AMGN) - 2.04%
N/A
#22
BEONE MEDICINES LTD ADR (ONC) - 1.95%
N/A
#23
ZYMEWORKS INC REGISTERED SHS (ZYME) - 1.62%
N/A
#24
FIRST AMERICAN TREASURY OBLIGS X (FXFXX) - 1.47%
N/A
#25
ANAPTYSBIO INC (ANAB) - 1.25%
N/A
Total Holdings571

CANC vs FAAR - Historical Returns

Returns include dividend reinvestment.

1M
Winner
CANC
-0.45%
FAAR
-2.79%
3M
Winner
CANC
+3.17%
FAAR
-1.84%
6M
CANC
+8.22%
Winner
FAAR
+22.36%
1Y
Winner
CANC
+43.36%
FAAR
+32.87%
5Y(CAGR)
CANC
-9.38%
Winner
FAAR
+7.52%
10Y(CAGR)
CANC
N/A
FAAR
+4.91%
Max(CAGR)
CANC
-9.38%
Winner
FAAR
+4.88%

CANC vs FAAR - Annual Returns (2016 - 2026)

Returns include dividend reinvestment.

YearCANCFAAR
2026+8.37%+22.25%
2025+42.13%+6.84%
2024-6.11%+5.74%
2023+515.06%-4.73%
2022-85.58%+10.10%
2021-51.82%+12.29%
2020N/A+11.07%
2019N/A-1.61%
2018N/A-8.92%
2017N/A+5.00%
2016N/A-3.78%

CANC vs FAAR Drawdown Comparison

The maximum drawdown for CANC was -97.53%, occurring on Apr 5, 2023. This drawdown has not yet recovered.

The maximum drawdown for FAAR was -18.06%, occurring on Apr 8, 2025. Recovery took 901 trading sessions.

The current CANC drawdown is -55.25%. The current FAAR drawdown is -3.52%.

RankCANCFAAR
#1-97.53%
Oct 20, 2021 - Apr 5, 2023
-18.06%
Jun 9, 2022 - Jan 13, 2026
#2-16.18%
Oct 5, 2021 - Oct 20, 2021
-16.65%
May 21, 2018 - Feb 22, 2021
#3N/A-12.20%
Jul 13, 2021 - Feb 7, 2022
#4N/A-6.77%
May 3, 2017 - Jan 11, 2018
#5N/A-6.33%
Mar 8, 2022 - Jun 9, 2022
#6N/A-5.93%
Jul 13, 2016 - May 3, 2017
#7N/A-5.87%
Jun 8, 2021 - Jul 13, 2021
#8N/A-5.76%
Jan 24, 2018 - May 21, 2018
#9N/A-3.63%
Feb 24, 2021 - Apr 29, 2021
#10N/A-3.52%
May 18, 2026 - Jun 9, 2026
#11N/A-2.88%
Jan 29, 2026 - Feb 19, 2026
#12N/A-2.70%
Mar 20, 2026 - Apr 2, 2026
#13N/A-2.24%
Apr 30, 2026 - May 18, 2026
#14N/A-2.03%
Feb 11, 2022 - Feb 22, 2022
#15N/A-1.98%
Feb 23, 2022 - Mar 1, 2022

Correlation

Correlation between CANC and FAAR is 0.26 which considered as a very weak or no correlation - the stocks move independently of each other.

0.26
-101

Dividend Comparison (2017 - 2026)

CANC vs FAAR dividend yield comparison.

YearCANCFAAR
20260.00%0.33%
20250.06%11.63%
20243.00%3.45%
20230.56%3.20%
20220.00%5.82%
20210.00%6.49%
20200.00%3.05%
20190.00%1.02%
20180.00%0.58%
20170.00%2.83%

Select Stocks to Compare